HEMOBLAST Pivotal Clinical Investigation

NACompletedINTERVENTIONAL
Enrollment

258

Participants

Timeline

Start Date

July 18, 2016

Primary Completion Date

February 1, 2017

Study Completion Date

March 27, 2017

Conditions
Hemostasis
Interventions
DEVICE

HEMOBLAST Bellows

DEVICE

Absorbable gelatin sponge, USP with thrombin

Trial Locations (17)

20814

Suburban Hospital - Johns Hopkins Medicine, Bethesda

Unknown

CORE Institute, Phoenix

University of California Los Angeles, Los Angeles

University of Southern California, Los Angeles

Lotus Clinical Research, Pasadena

Miami Plastic Surgery, Miami

Queens Medical Center, Honolulu

Washington University in St. Louis, St Louis

Dartmouth Hitchcock Medical Center, Hanover

Columbia University Medical Center / New York Presbyterian Hospital, New York

Icahn School of Medicine at Mount Sinai, New York

University of North Carolina at Chapel Hill, Chapel Hill

Duke University, Durham

Hunstad Kortesis Center, Huntsville

Intermountain Liver Disease and Transplant Center, Murray

University of Virginia, Charlottesville

Spectrum Medical, Danville

All Listed Sponsors
lead

Biom'Up France SAS

INDUSTRY

NCT02780869 - HEMOBLAST Pivotal Clinical Investigation | Biotech Hunter | Biotech Hunter